Table 1.
Laboratory Parameters upon Admission to Our Hospital.
| Hematology | Tumor markers | Cerebrospinal fluid test | ||||||
| WBC | 6,900 | /μL | AFP | 2 | U/mL | Cell counts | 1 | /μL |
| Neut | 89.7 | % | CEA | 1.1 | ng/mL | Specific gravity | 1.005 | |
| Lymph | 5.8 | % | DCP | 72 | mAU/mL | |||
| Mono | 4.5 | % | ||||||
| Eos | 0.0 | % | Serology | |||||
| Baso | 0.0 | % | IgG | 2,029 | mg/dL | |||
| RBC | 3.85 | ×106/μL | IgM | 46 | mg/dL | |||
| Hb | 11.1 | g/dL | IgA | 416 | mg/dL | |||
| Ht | 36.6 | % | ANA | 160 | ||||
| PLT | 34.1 | ×104/μL | RF | 9 | U/mL | |||
| DNA antibody | 11 | IU/mL | ||||||
| Biochemistry | SS-A antibody | 3,620 | U/mL | |||||
| TP | 8.3 | g/dL | SS-B antibody | 333 | U/mL | |||
| ALB | 3.3 | g/dL | Scl-70 antibody | <1.0 | U/mL | |||
| T-BIL | 0.9 | mg/dL | SM antibody | 4.3 | U/mL | |||
| AST | 27 | U/L | MPO-ANCA | <1.0 | U/mL | |||
| ALT | 20 | U/L | PR3-ANCA | 1.1 | U/mL | |||
| ALP | 245 | U/L | ||||||
| GGT | 78 | U/L | Hepatitis virus | |||||
| LDH | 173 | U/L | HBs antigen | (-)<0.02 | IU/mL | |||
| BUN | 11.4 | mg/dL | HBs antibody | (-)<1.0 | IU/mL | |||
| Cr | 0.75 | mg/dL | HBc antibody | (-) | S/CO | |||
| Na | 136 | mEq/L | HCV antibody | (-) | COI | |||
| K | 3.4 | mEq/L | CMV-IgM | 0.18 (-) | ||||
| Cl | 97 | mEq/L | CMV-IgG | 2.4 (+-) | ||||
| Uric acid | 3.5 | mg/dL | EBV-VCA-IgM | <40 (-) | ||||
| Ferritin | 516 | ng/dL | EBV-VCA-IgG | 40(-) | ||||
| NH3 | 132 | μg/dL | EBV-EBNA | 40 | ||||
| CRP | 29.24 | mg/dL | VZV-IgM | 0.33 (-) | ||||
| VZV-IgG | 12.2 (+) | |||||||
| Coagulation | HSV-IgM | <4 (-) | ||||||
| PT-INR | 1.21 | HSV-IgG | 3.2 (+-) | |||||
| PT% | 69.4 | % | T-SPOT | (-) | ||||
| PT control | 11.3 | s | β-D gulcan | 22.3 | pg/mL | |||
| PT | 13.6 | s | Cryptococcus antigen | (-) | ||||
| APTT control | 27.8 | s | Aspergillus antigen | (-) | ||||
| APTT | 30.2 | s | ||||||
| FDP | 9.7 | μg/mL | Urine | |||||
| D-dimer | 3.4 | μg/mL | WBC | (-) | ||||
| fibrinogen | 766 | mg/dL | ||||||
WBC: white blood cell, RBC: red blood cell, Hb: hemoglobin, Lymph: lymphocyte, Mono: monocyte, Eos: eosinophil granulocyte, Baso: basophil leucocyte, Ht: hematocrit, PLT: platelet, TP: total protein, ALB: albumin, T-BIL: total bilirubin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, ALP: alkaline phosphatase, GGT: gamma-glutamyl transferase, LDH: lactate dehydrogenase, BUN: blood urea nitrogen, Cr: creatinine, Na: sodium, K: potassium, Cl: chloride, NH3: ammonia, CRP: C-reactive protein, PT-INR: international normalized ratio of prothrombin time, PT: prothrombin time, APTT: activated partial thromboplastin time, FDP: fibrin degradation product, AFP: α-fetoprotein, CEA: carcinoembryonic antigen, DCP: des-gamma-carboxy prothrombin, IgG: immunoglobulin G, IgM: immunoglobulin M, IgA: immunoglobulin A, ANA: antinuclear antigen, RF: rheumatic factor, DNA antibody: anti-native DNA antibody, SS-A antibody: anti-Sjögren syndrome-A antibody, SS-B antibody: anti-Sjögren syndrome-B antibody, Scl-70 antibody: anti-scleroderma antibody, SM antibody: anti-SM antibody, MPO-ANCA: myeloperoxidase antineutrophil cytoplasmic antibody, PR3-ANCA: proteinase3 antineutrophil cytoplasmic antibody, HBs antigen: hepatitis B surface antigen, HBc antibody: hepatitis B core antibody, HCV: hepatitis C virus, CMV: cytomegalovirus, EBV-VCA: Epstein-Barr virus-viral capsid antigen antibody, EBV-EBNA: EB virus nuclear antigen, VZV: Varicella and herpes zoster vaccines, HSV: herpes simplex virus